ReviewDie Ophthalmologie2026
Endophthalmitis with keratitis-how to manage severe cases? : A narrative review.
Review in Die Ophthalmologie, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Endophthalmitis secondary to microbial keratitis (MK) is a rare but devastating ophthalmic emergency characterized by diagnostic and therapeutic challenges due to poor corneal clarity. Although it accounts for less than 10% of cases of exogenous endophthalmitis, it often results in poor visual outcomes or enucleation. The most common causative organisms include Staphylococcus spp., Pseudomonas spp., and Fusarium spp., with rising concerns about antimicrobial resistance. Several risk factors have been identified, including the use of topical corticosteroids, systemic immunosuppression, and fungal infections, particularly those caused by Fusarium. Early and aggressive management is essential, combining intravitreal antimicrobials with surgery to reduce the microbiological load. When corneal opacity limits visualization, a combined approach involving temporary keratoprosthesis, penetrating keratoplasty, and pars plana vitrectomy may offer a chance to salvage the eye. This narrative review synthesizes the current understanding of MK-associated endophthalmitis and presents updated management strategies to optimize visual and anatomical outcomes in these severe cases.
Indexed as
Identifiers
41326823What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.